🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Emre Yekedüz Ankara Üniversitesi Beliz Bahar Karaoğlan ESMO - Eur. Oncology OncoAlert 🌟 Rising star alert! Beliz Bahar Karaoğlan from Ankara Üniversitesi receives an ESMO - Eur. Oncology Merit Travel Grant. Proud moment! OncoAlert Dr Joseph McCollom DO

Inviting all Young Oncologists to #ESMOYOC sessions at #ESMOGI25 Starting today with Mentorship Session with three great speakers at 12:45 ESMO - Eur. Oncology OncoDaily Jakob Nikolas Kather Rodrigo Sánchez-Bayona Elene Mariamidze Liz Connolly Pawel Sobczuk Myrto K. Moutafi Hongcheng Zhu 祝鸿程 Saad Nasir, MD Pablo Mando

The OncoAlert VJ Oncology JOURNAL CLUB This week we have the pleasure to bring you Dr. Ali Shamseddine for the American University of Beirut 🇱🇧American University of Beirut American University of Beirut Medical Center Discussing his paper: Short Course Radiation Followed by mFOLFOX6 plus Avelumab for locally Advanced

🔥 TALENTACE (ESMO GI 2025) in unresectable HCC 🧪 TACE + AtezoBev vs TACE alone (n=342) ✅ TACE-PFS: 11.3 vs 7.0 mo ➡️ HR 0.71 | p=0.009 ✅ ORR (RECIST): 49.1% vs 33.9% ❌ OS: 34.5 vs 35.4 mo | NS 📌 Better local control, no OS gain. #ESMOGI25 ESMO - Eur. Oncology OncoAlert

⭐️Poster session at #ESMOGI has started!Come check out my poster 429P–Prognostic Significance of HER2-Low Status in Advanced Gastric Cancer. If you're interested in and potential collaboration,I'd be happy to connect! ESMO - Eur. Oncology Yüksel Ürün Deniz Can Guven Erman Akkus Ankara Üniversitesi

🟠Poster session in #ESMOGI25 📋A lot of great studies in the poster session ✅Thanks all authors and ESMO - Eur. Oncology for this rich content! #cancer #oncology #biliary #MedX Beliz Bahar Karaoğlan Deniz Can Guven

Our amazing ⭐️⭐️⭐️ fellow Erman Akkus from Ankara Üniversitesi is presenting his study at #ESMOGI25 ! Drop by and take a peek! His studies are always eye-opener! Yüksel Ürün OncoAlert Deniz Can Guven Beliz Bahar Karaoğlan Dr Joseph McCollom DO

It couldn't be missed out! My dear friend Deniz Can Guven , a member of ESMO - Eur. Oncology #ESMOYOC , is chairing the great sessions for all young oncologists at #ESMOGI25 ! Rodrigo Sánchez-Bayona Yüksel Ürün OncoAlert Matteo Lambertini, MD PhD Erman Akkus Beliz Bahar Karaoğlan Ömer Dizdar Sercan Aksoy, MD

Beliz Bahar Karaoğlan ESMO - Eur. Oncology Yüksel Ürün Deniz Can Guven Erman Akkus Ankara Üniversitesi Excellent work! Now that you show strongly how vulnerable this population is, more studies for intervention are warranted #GIonc

Durvalumab approved in the 🇪🇺EU as the first and only perioperative immunotherapy for muscle-invasive bladder cancer. Based on NIAGARA trial: 32% ⬇️recurrence risk, 25%⬇️ risk of death. Proud to be part of this journey as a study site. OncoAlert World Bladder Cancer Patient Coalition Tom Powles

Keynote lecture now by Frank Sinicrope, MD on CRC screening using blood-based tests and more. Chaired by Eric van Cutsem. ESMO - Eur. Oncology #ESMOAmbassadors #ESMOGI25

🧪 Blood-based tests are shaking up CRC screening! #ESMOGI25 🔬 cfDNA (SHIELD, FREEDOME): sensitivity 83–91.5% 🧻 ColoSense™: 94% CRC sensitivity, FDA approved 📈 Real-world impact driven by better adherence 🧠 From FIT to futuristic—CRC screening is getting a liquid upgrade!

We continue #ESMOYOC activities at #ESMOGI25 today at 12:45pm ⏱️⏱️ We have 3️⃣ great speakers to discuss building a career in GI oncology 💯💯 Expecting all YOs to join for valuable insights ✅✅ ESMO - Eur. Oncology OncoDaily Arndt Vogel Rachel Riechelmann Josep Tabernero Rille

Grateful to ESMO - Eur. Oncology for the chance to share my perspective on agnostic cancer therapies and their role in advancing precision medicine in GI tumours. Huge thanks to the incredible chairs and speakers of this session - I feel very privileged to have been a part of it. #ESMOGI25

✅ Summary discussion of proffered papers ctDNA-guided surveillance in CRC 👇 ESMO - Eur. Oncology #ESMOGI25 #cancer #oncology #colon #MedX

Truly a #legacy podcast for me as this was the last conversation I had with my dear #mentor and #hpm friend the late Dr John Mulder. Grateful he let me share my heart for #pallonc #supponc and #survonc. More poignant it comes on the heels of our #paper 🍎:

Recurrence Patterns of Esophageal Adenocarcinoma in the Phase III ESOPEC Trial Comparing FLOT With CROSS 💥FLOT enhances survival through superior systemic control, with locoregional control similar to CROSS ascopubs.org/doi/10.1200/JC…

Congratulations to Dr Joseph McCollom DO on his first publication! 🎉 A great piece highlighting key teaching points and critical insights in supportive care. Looking forward to more😌

👇Our study from International Journal of Cancer on EOCRC ➡️Stage-specific characterization 🚨More than 90% is symptomatic, even in localized stage ❗️Screening? ✅No survival difference 🔴RAS mutation is prognostic for localized disease 🔴RAS mutation➡️metastatic presentation onlinelibrary.wiley.com/doi/10.1002/ij…

Dr Christine Parseghian, MD summarizes #CAIRO6 for #BoA25 🔑 takeaways including the prolonged #PFS and #DFS but not #OS in this population but no #RAF and #RAS testing limits applicability and #PROTEGE limits value of #HIPEC in this population #GIonc #BestofASCO ASCO Nicole L. Stout DPT, FAPTA